Ikuyo Yamaguchi1, Coral Hanevold2. 1. Department of Pediatrics, Division of Nephrology, University of Texas Health San Antonio, 7703 Floyd Curl Drive, Mail Code 7813, San Antonio, Texas, 78229-3900, USA. yamaguchi@uthscsa.edu. 2. Department of Pediatrics, Division of Nephrology, University of Washington School of Medicine, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA, 98105, USA.
Abstract
PURPOSE OF REVIEW: To understand the impact of attention deficit hyperactivity disorder (ADHD) and its medications on blood pressure (BP) in children and adolescents and provide recommendations for management of elevated BP in children and adolescents with ADHD. RECENT FINDINGS: ADHD medications have cardiovascular effects including elevated BP. However, the bulk of the evidence indicates that stimulants and other ADHD medications are safe and do not cause severe cardiovascular diseases. BP should be assessed carefully at the time of ADHD diagnosis, because some behavioral changes similar to ADHD may be associated with hypertension. ADHD medications appear to be safe. However, their long-term impact on the cardiovascular system is not clearly understood and needs further investigation. BP should be monitored regularly during ADHD pharmacotherapy in order to optimize the management of both conditions.
PURPOSE OF REVIEW: To understand the impact of attention deficit hyperactivity disorder (ADHD) and its medications on blood pressure (BP) in children and adolescents and provide recommendations for management of elevated BP in children and adolescents with ADHD. RECENT FINDINGS:ADHD medications have cardiovascular effects including elevated BP. However, the bulk of the evidence indicates that stimulants and other ADHD medications are safe and do not cause severe cardiovascular diseases. BP should be assessed carefully at the time of ADHD diagnosis, because some behavioral changes similar to ADHD may be associated with hypertension. ADHD medications appear to be safe. However, their long-term impact on the cardiovascular system is not clearly understood and needs further investigation. BP should be monitored regularly during ADHD pharmacotherapy in order to optimize the management of both conditions.
Authors: Tanya E Froehlich; Bruce P Lanphear; Jeffery N Epstein; William J Barbaresi; Slavica K Katusic; Robert S Kahn Journal: Arch Pediatr Adolesc Med Date: 2007-09
Authors: Amanda J Shillingford; Marianne M Glanzman; Richard F Ittenbach; Robert R Clancy; J William Gaynor; Gil Wernovsky Journal: Pediatrics Date: 2008-04 Impact factor: 7.124
Authors: Joachim F Wernicke; Douglas Faries; Donald Girod; Jeffrey Brown; Haitao Gao; Douglas Kelsey; Humberto Quintana; Robert Lipetz; David Michelson; John Heiligenstein Journal: Drug Saf Date: 2003 Impact factor: 5.606
Authors: Cindy D Stowe; Stephanie F Gardner; Charles C Gist; Eldon G Schulz; Thomas G Wells Journal: Ann Pharmacother Date: 2002 Jul-Aug Impact factor: 3.154